Antonenko S, Telegeev G. Inhibition of USP1, a new partner of Bcr-Abl, results in decrease of Bcr-Abl level in K562 cells. Exp. oncol. [Internet]. 2023 Jun. 1 [cited 2026 Jun. 27];42(2):109-14. Available from: https://exp-oncology.com.ua/index.php/Exp/article/view/2020-2-10